These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9316852)

  • 21. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.
    Ai Y; Markesbery W; Zhang Z; Grondin R; Elseberry D; Gerhardt GA; Gash DM
    J Comp Neurol; 2003 Jun; 461(2):250-61. PubMed ID: 12724841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease.
    Wartiovaara K; Hytönen M; Vuori M; Paulin L; Rinne J; Sariola H
    Exp Neurol; 1998 Aug; 152(2):307-9. PubMed ID: 9710530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
    Gill SS; Patel NK; Hotton GR; O'Sullivan K; McCarter R; Bunnage M; Brooks DJ; Svendsen CN; Heywood P
    Nat Med; 2003 May; 9(5):589-95. PubMed ID: 12669033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X; Hagg T
    J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease.
    Tsuboi K; Shults CW
    Exp Neurol; 2002 Jan; 173(1):95-104. PubMed ID: 11771942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats.
    Hermann DM; Kilic E; Kügler S; Isenmann S; Bähr M
    Neurobiol Dis; 2001 Dec; 8(6):964-73. PubMed ID: 11741392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
    Shingo T; Date I; Yoshida H; Ohmoto T
    J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
    Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation.
    Xu K; Dluzen DE
    Exp Neurol; 2000 Dec; 166(2):450-7. PubMed ID: 11085910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Growth factors as neuroprotective treatment in Parkinson disease?].
    Torp R; Singh PB; Sørensen DR; Dietrichs E; Hirschberg H
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):899-901. PubMed ID: 16554879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective and neurorestorative properties of GDNF.
    Gash DM; Zhang Z; Gerhardt G
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S121-5. PubMed ID: 9749583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
    San Sebastián W; Guillén J; Manrique M; Belzunegui S; Ciordia E; Izal-Azcárate A; Garrido-Gil P; Vázquez-Claverie M; Luquin MR
    Brain; 2007 May; 130(Pt 5):1306-16. PubMed ID: 17439984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys.
    Grondin R; Zhang Z; Yi A; Cass WA; Maswood N; Andersen AH; Elsberry DD; Klein MC; Gerhardt GA; Gash DM
    Brain; 2002 Oct; 125(Pt 10):2191-201. PubMed ID: 12244077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GDNF, a multispecific neurotrophic factor with potential therapeutic applications in neurodegenerative disorders.
    Arenas E
    Mol Psychiatry; 1996 Jul; 1(3):179-82. PubMed ID: 9118339
    [No Abstract]   [Full Text] [Related]  

  • 39. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor.
    Slevin JT; Gerhardt GA; Smith CD; Gash DM; Kryscio R; Young B
    J Neurosurg; 2005 Feb; 102(2):216-22. PubMed ID: 15739547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease.
    Kordower JH; Palfi S; Chen EY; Ma SY; Sendera T; Cochran EJ; Cochran EJ; Mufson EJ; Penn R; Goetz CG; Comella CD
    Ann Neurol; 1999 Sep; 46(3):419-24. PubMed ID: 10482276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.